Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

94
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
94
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
Gut-Brain Axis01:22

Gut-Brain Axis

125
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
125
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

77
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
77
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

112
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
112
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

60
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recompensation and Further Decompensation After Index Decompensation in Patients with Autoimmune Hepatitis: A Real-World Study.

Digestive diseases and sciences·2026
Same author

Development of RPA and nested-RPA based CRISPR/Cas13a diagnostic platform for the identification of HBV DNA and HCV RNA in Indian patient cohort.

Diagnostic microbiology and infectious disease·2026
Same author

Decision-making in vascular liver disorders during the reproductive period: Bridging evidence gaps and clinical practice.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Genome-Wide Association Study to Identify Novel Genetic Variants Associated With Primary Budd-Chiari Syndrome.

Journal of clinical and experimental hepatology·2026
Same author

Gut colonization with multidrug-resistant organisms in hospitalized patients with gastrointestinal illness: A single-centre, cross-sectional study.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Exploring role of therapeutic plasma exchange for hepatitis A-related acute liver failure: An Indian multi-center cohort study.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026

Related Experiment Video

Updated: Apr 16, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.6K

Gut microbiome and liver diseases.

Shalimar1

  • 1Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.

Journal of Clinical and Experimental Hepatology
|March 11, 2015
PubMed
Summary
This summary is machine-generated.

Alterations in the human gut microbiome are linked to liver cirrhosis. This study investigates the gut microbial community changes in patients with liver cirrhosis, identifying key shifts in bacterial populations.

Keywords:
CDR, cirrhosis dysbiosis ratioHMP, Human Microbiome Projectbacteriacirrhosisgenome

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.6K
Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
06:23

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota

Published on: February 15, 2019

15.0K

Related Experiment Videos

Last Updated: Apr 16, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.6K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.6K
Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
06:23

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota

Published on: February 15, 2019

15.0K

Area of Science:

  • Gastroenterology and Hepatology
  • Microbiology
  • Genetics

Background:

  • Liver cirrhosis is a severe liver disease characterized by chronic inflammation and fibrosis.
  • The gut microbiome plays a crucial role in maintaining liver health, and dysbiosis has been implicated in various liver diseases.
  • Understanding the specific alterations in the gut microbiome associated with liver cirrhosis is essential for developing targeted therapeutic strategies.

Purpose of the Study:

  • To investigate the composition and function of the human gut microbiome in patients with liver cirrhosis.
  • To identify specific microbial signatures associated with the progression and severity of liver cirrhosis.
  • To explore the potential role of gut dysbiosis in the pathogenesis of liver cirrhosis.

Main Methods:

  • 16S rRNA gene sequencing was employed to analyze the gut microbial communities of cirrhotic patients and healthy controls.
  • Metagenomic sequencing was used to assess the functional potential of the gut microbiome.
  • Bioinformatic analyses were performed to compare microbial diversity, composition, and functional profiles between groups.

Main Results:

  • Significant alterations in gut microbiome composition were observed in liver cirrhosis patients compared to healthy controls, characterized by decreased diversity and altered abundance of specific bacterial taxa.
  • Key phyla such as Firmicutes and Bacteroidetes showed significant changes, with specific genera exhibiting distinct enrichment or depletion in cirrhotic individuals.
  • Functional analysis revealed alterations in metabolic pathways related to bile acid metabolism, amino acid synthesis, and energy production in the gut microbiome of patients with liver cirrhosis.

Conclusions:

  • The human gut microbiome is significantly altered in liver cirrhosis, indicating a strong association between gut dysbiosis and the disease.
  • These microbial alterations may contribute to the pathogenesis of liver cirrhosis through various mechanisms, including altered metabolite production and inflammation.
  • Targeting the gut microbiome represents a potential therapeutic avenue for managing liver cirrhosis.